Skip to main content
Home
language-selector-globe Slovenia | en
Choose Location
language-selector-globe Slovenia |
EnglishSlovenian
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | es
Brazil | pt
Canada | en
Canada | fr
Central America | es
Colombia | es
Latin America | es
Mexico | es
United States | en
Venezuela | es
Australia | en
Bangladesh | en
Hong Kong S.A.R. | zh
India | en
Indonesia | en
Japan | ja
Korea | ko
Mainland China | zh
Malaysia | en
Pakistan | en
Philippines | en
Singapore | en
Taiwan | zh
Austria | de
Belgium | fr
Belgium | nl
Bulgaria | bg
Czech Republic | cs
Czech Republic | en
Denmark | da
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hungary | hu
Ireland | en
Israel | he
Italy | it
Latvia | lv
Lithuania | lt
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Serbia | sr
Slovakia | sk
Slovenia | sl
Slovenia | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
United Kingdom | en
Novartis | en
Sandoz | en
Egypt | en
South Africa | en
Turkey | tr
language-selector-globe si
Choose Location
language-selector-globeSlovenia
EnglishSlovenian
Americas Asia Pacific Europe International Middle East & Africa
Argentina | es
Australia | en
Austria | de
Bangladesh | en
Belgium | fr
Belgium | nl
Brazil | pt
Bulgaria | bg
Canada | en
Canada | fr
Central America | es
Colombia | es
Czech Republic | cs
Czech Republic | en
Denmark | da
Egypt | en
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hong Kong S.A.R. | zh
Hungary | hu
India | en
Indonesia | en
Ireland | en
Israel | he
Italy | it
Japan | ja
Korea | ko
Latin America | es
Latvia | lv
Lithuania | lt
Mainland China | zh
Malaysia | en
Mexico | es
Netherlands | nl
Norway | no
Novartis | en
Pakistan | en
Philippines | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Sandoz | en
Serbia | sr
Singapore | en
Slovakia | sk
Slovenia | sl
Slovenia | en
South Africa | en
Spain | es
Sweden | sv
Switzerland | de
Switzerland | fr
Taiwan | zh
Turkey | tr
United Kingdom | en
United States | en
Venezuela | es
    • About 
      • Novartis in Slovenia 
      • Country Leadership Team 
      • Strategy 
      • Diversity, Equity and Inclusion 
      • People and culture 
      • Products 
      • Contacts 
      Novartis in Slovenia. Scientist in laboratory About
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Adverse Event Reporting 
      • Diseases 
      • Products 
      Older patient and younger caregiver Patients and Caregivers
    • Healthcare Professionals 
      • Healthcare professional country resource 
      • Products 
      • Pipeline 
      • Adverse Event Reporting 
      • Clinical studies 
      Elderly gentleman at a doctor's appointment Healthcare Professionals
    • ESG 
      • Ethics, risk and compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      • Ethical Behavior 
      • Reporting 
      Two people holding hands ESG
    • Media 
      • News Archive 
      • Media Contact 
      Man reading newspaper Media
    • Careers 
      • Careers at Novartis in Slovenia 
      • How We Work 
      • Wellbeing 
      • Diversity, Equity and Inclusion 
      • BioCamp 
      • Meet the teams 
      • Personal Growth 
      • Early Talent 
      • Awards and Recognition 
      Man and woman behind computer Careers
    • Development and production of innovative medicines 
    • BioCamp 2024 
    Scientist, Novartis in Slovenia Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business
  • Functional Area Sort descending
  • Date Posted
Job Title Site Location Division Business Functional Area Sort descending Date Posted
Solution Design Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing 03 September 2024
TA Strategy Lead - GenMed Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing 02 October 2024
CX strategy Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing 04 October 2024
RLT Sasayama_Associate_Finance Business Planning and Analysis Sasayama Japan Finance Innovative Medicines Audit & Finance 17 September 2024
Manager, Financial Control & Compliance (FC&C) Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit & Finance 06 October 2024
Associate, Record-to-Report Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit & Finance 26 June 2024
Agile Project Management Lead Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Technology Transformation 01 July 2024

Pagination

  • ‹ Previous page
  • 1
  • 2

Novartis Slovenia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • Media
  • Career
Media
  • News Archive
Our Portfolio
  • Novartis Products
  • Novartis Pipeline
Other Novartis websites
  • Global site
Footer Bottom
© 2024 Novartis d.o.o.
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for a global audience